AKT-dependent phosphorylation of the adenosine deaminases ADAR-1 and -2 inhibits deaminase activity.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 17 5 2019
medline: 2 6 2020
entrez: 17 5 2019
Statut: ppublish

Résumé

Murine thymoma viral oncogene homolog (AKT) kinases target both cytosolic and nuclear substrates for phosphorylation. Whereas the cytosolic substrates are known to be closely associated with the regulation of apoptosis and autophagy or metabolism and protein synthesis, the nuclear substrates are, for the most part, poorly understood. To better define the role of nuclear AKT, potential AKT substrates were isolated from the nuclear lysates of leukemic cell lines using a phosphorylated AKT substrate antibody and identified in tandem mass spectrometry. Among the proteins identified was adenosine deaminase acting on RNA (ADAR)1p110, the predominant nuclear isoform of the adenosine deaminase acting on double-stranded RNA. Coimmunoprecipitation studies and

Identifiants

pubmed: 31095429
doi: 10.1096/fj.201800490RR
doi:

Substances chimiques

RNA-Binding Proteins 0
Recombinant Proteins 0
AKT1 protein, human EC 2.7.11.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
ADAR protein, human EC 3.5.4.37
ADARB1 protein, human EC 3.5.4.4
Adenosine Deaminase EC 3.5.4.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9044-9061

Auteurs

Alberto Bavelloni (A)

IRCSS Istituto Ortopedico Rizzoli (IOR), Bologna, Italy.

Enrico Focaccia (E)

IRCSS Istituto Ortopedico Rizzoli (IOR), Bologna, Italy.
National Research Council (CNR) of Italy, Institute of Molecular Genetics (IGM), Bologna, Italy.

Manuela Piazzi (M)

IRCSS Istituto Ortopedico Rizzoli (IOR), Bologna, Italy.
National Research Council (CNR) of Italy, Institute of Molecular Genetics (IGM), Bologna, Italy.

Mirco Raffini (M)

IRCSS Istituto Ortopedico Rizzoli (IOR), Bologna, Italy.

Valeriana Cesarini (V)

Oncohaematology Department, RNA Editing Laboratory, IRCCS-Ospedale Pediatrico Bambino Gesù, Rome, Italy; and.

Sara Tomaselli (S)

Oncohaematology Department, RNA Editing Laboratory, IRCCS-Ospedale Pediatrico Bambino Gesù, Rome, Italy; and.

Arianna Orsini (A)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Stefano Ratti (S)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Irene Faenza (I)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Lucio Cocco (L)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Angela Gallo (A)

Oncohaematology Department, RNA Editing Laboratory, IRCCS-Ospedale Pediatrico Bambino Gesù, Rome, Italy; and.

William L Blalock (WL)

IRCSS Istituto Ortopedico Rizzoli (IOR), Bologna, Italy.
National Research Council (CNR) of Italy, Institute of Molecular Genetics (IGM), Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH